StockNews.AI
FLGT
StockNews.AI
78 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT

1. Pomerantz LLP investigating Fulgent Genetics for potential securities fraud. 2. Fulgent received a civil investigative demand from the DOJ regarding false claims. 3. Stock price fell 2.61% following the disclosure of the DOJ investigation. 4. Investors are advised to join the class action for potential claims. 5. Pomerantz LLP is a well-regarded firm in securities class litigation.

3m saved
Insight
Article

FAQ

Why Bearish?

The investigation suggests significant legal risk, impacting investor confidence and stock performance. Historical cases indicate serious financial repercussions for firms under inquiry.

How important is it?

The ongoing legal scrutiny can lead to further price declines if unresolved. Such investigations can result in long-term ramifications for corporate reputation and stock performance.

Why Short Term?

Immediate market reaction seen post-disclosure can lead to volatility. Similar past events caused quick price drops for affected companies.

Related Companies

NVTACGIXRGLS
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fulgent and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On February 28, 2025, Fulgent disclosed in its annual report, filed with the U.S. Securities and Exchange Commission, that it had received a civil investigative demand from the U.S. Department of Justice regarding potential false claims submitted under the Uninsured Program.  On this news, Fulgent’s stock price fell $0.41 per share, or 2.61%, over the following two trading sessions, to close at $15.28 per share on March 3, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.  CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News